4D Molecular Therapeutics
Price & Volume
Stats
See moreOpen | $10.02 |
Previous Close | $10.04 |
Day Range | $9.64-$10.11 |
52W Range | $2.88-$12.34 |
Market Cap | $500.8M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $85.2M |
Revenue Growth (YoY) | 8,508,900% |
Gross Profit (12 Mos) | -$107.2M |
Diluted EPS | -$2.42 |
News
See moreYahoo Finance • 27 days ago
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
Yahoo Finance • 2 months ago
4DMT to Participate in Upcoming Investor Conferences
Yahoo Finance • 2 months ago
4DMT Announces New Employment Inducement Grants
Yahoo Finance • 2 months ago
Barclays Flags M&A Tailwinds and Pricing Relief as Upside Catalysts for 4D Molecular Therapeutics, Inc. (FDMT)
About
CEO | Dr. David H. Kirn M.D. |
CFO | Mr. Kristian Humer M.B.A. |
Address | 5858 Horton Street, EmeryVille, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 196 |
